Author

Qingxing Wang

Universität UlmORCID 0000-0003-1028-1267Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Frank KirchhoffiD· 2 shared Konstantin M. J. SparreriD· 2 shared Qinya Xie· 2 shared Sabrina NoettgeriD· 2 shared Alexander Graf· 1 shared Alina SeideliD· 1 shared Annika C. BetzleriD· 1 shared Chiara PastorioiD· 1 shared

Activity by Year

2020-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Frank KirchhoffORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyJournal of VirologyPeer-reviewedMay 7, 2026

Replication-competent SIVcpz CRISPR screen identifies barriers to successful cross-species transmission

Qinya Xie, Qingxing Wang, Sabrina Noettger…·Frank Kirchhoff

CRISPR screens with replication-competent SIVcpz identify human antiviral factors limiting efficient viral replication after zoonotic transmission.

1 citation

humangenetic perturbation / CRISPR

𝕏 PostBluesky

Molecular BiologyCommunications BiologyPeer-reviewedOct 17, 2023

Determinants of species-specific utilization of ACE2 by human and animal coronaviruses

Qingxing Wang, Sabrina Noettger, Qinya Xie…·Frank Kirchhoff

The paper identifies key mutations in SARS-CoV-2 and bat coronaviruses that affect ACE2 receptor usage across different species and shows that vaccinated individuals' sera neutralize bat Sarbecovirus Spike proteins.

15 citations

𝕏 PostBluesky

Molecular BiologybioRxivPreprintOct 6, 2020

Structural basis for repurposing a 100-years-old drug suramin for treating COVID-19

Wanchao Yin, Xiaodong Luan, Zhihai Li…·H. Eric Xu

The paper discovers suramin as a potent inhibitor of SARS-CoV-2 RNA polymerase and provides its structural mechanism for repurposing in treating COVID-19.

5 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky